Search details
1.
The menin-MLL1 interaction is a molecular dependency in NUP98-rearranged AML.
Blood
; 139(6): 894-906, 2022 02 10.
Article
in English
| MEDLINE | ID: mdl-34582559
2.
CD74 is expressed in a subset of pediatric acute myeloid leukemia patients and is a promising target for therapy: a report from the Children's Oncology Group.
Haematologica
; 2024 Feb 01.
Article
in English
| MEDLINE | ID: mdl-38299667
3.
Aberrant T-cell exhaustion in severe combined immunodeficiency survivors with poor T-cell reconstitution after transplantation.
J Allergy Clin Immunol
; 151(1): 260-271, 2023 01.
Article
in English
| MEDLINE | ID: mdl-35987350
4.
Comprehensive molecular and clinical characterization of NUP98 fusions in pediatric acute myeloid leukemia.
Haematologica
; 108(8): 2044-2058, 2023 08 01.
Article
in English
| MEDLINE | ID: mdl-36815378
5.
Molecular and phenotypic diversity of CBL-mutated juvenile myelomonocytic leukemia.
Haematologica
; 107(1): 178-186, 2022 01 01.
Article
in English
| MEDLINE | ID: mdl-33375775
6.
CREBBP alterations are associated with a poor prognosis in de novo AML.
Blood
; 141(17): 2156-2159, 2023 04 27.
Article
in English
| MEDLINE | ID: mdl-36634304
7.
Integration of measurable residual disease by WT1 gene expression and flow cytometry identifies pediatric patients with high risk of relapse in acute myeloid leukemia.
Front Oncol
; 14: 1340909, 2024.
Article
in English
| MEDLINE | ID: mdl-38720804
8.
Genetic variation in DNA damage response pathway and response to Gemtuzumab Ozogamicin in pediatric AML: a report from the Children's Oncology Group.
Clin Cancer Res
; 2024 Jan 10.
Article
in English
| MEDLINE | ID: mdl-38197878
9.
Chromatin Profiles Are Prognostic of Clinical Response to Bortezomib-Containing Chemotherapy in Pediatric Acute Myeloid Leukemia: Results from the COG AAML1031 Trial.
Cancers (Basel)
; 16(8)2024 Apr 09.
Article
in English
| MEDLINE | ID: mdl-38672531
10.
BIRC5 expression is a poor prognostic marker in Ewing sarcoma.
Pediatr Blood Cancer
; 60(1): 35-40, 2013 Jan.
Article
in English
| MEDLINE | ID: mdl-22961763
11.
Trastuzumab Deruxtecan, Antibody-Drug Conjugate Targeting HER2, Is Effective in Pediatric Malignancies: A Report by the Pediatric Preclinical Testing Consortium.
Mol Cancer Ther
; 21(8): 1318-1325, 2022 08 02.
Article
in English
| MEDLINE | ID: mdl-35657346
12.
Assessment of Arsenic Trioxide and All-trans Retinoic Acid for the Treatment of Pediatric Acute Promyelocytic Leukemia: A Report From the Children's Oncology Group AAML1331 Trial.
JAMA Oncol
; 8(1): 79-87, 2022 Jan 01.
Article
in English
| MEDLINE | ID: mdl-34762093
13.
Comprehensive Surfaceome Profiling to Identify and Validate Novel Cell-Surface Targets in Osteosarcoma.
Mol Cancer Ther
; 21(6): 903-913, 2022 06 01.
Article
in English
| MEDLINE | ID: mdl-35312779
14.
ABBV-085, Antibody-Drug Conjugate Targeting LRRC15, Is Effective in Osteosarcoma: A Report by the Pediatric Preclinical Testing Consortium.
Mol Cancer Ther
; 20(3): 535-540, 2021 03.
Article
in English
| MEDLINE | ID: mdl-33298592
15.
Past, present and future of therapies in pediatric sarcomas.
Future Oncol
; 6(4): 605-18, 2010 Apr.
Article
in English
| MEDLINE | ID: mdl-20373872
16.
Quality of life in pediatric acute myeloid leukemia: Report from the Children's Oncology Group.
Cancer Med
; 8(9): 4454-4464, 2019 08.
Article
in English
| MEDLINE | ID: mdl-31190442
17.
Integrating mechanisms of response and resistance against the tubulin binding agent Eribulin in preclinical models of osteosarcoma.
Oncotarget
; 7(52): 86594-86607, 2016 Dec 27.
Article
in English
| MEDLINE | ID: mdl-27863409
18.
Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia.
J Clin Oncol
; 33(27): 2949-62, 2015 Sep 20.
Article
in English
| MEDLINE | ID: mdl-26304895
19.
The neuroradiological findings in a case of Revesz syndrome.
Pediatr Radiol
; 37(11): 1166-70, 2007 Nov.
Article
in English
| MEDLINE | ID: mdl-17874088
Results
1 -
19
de 19
1
Next >
>>